Ind-Swift gets PMDA approval from Japan;stk up

MUMBAI: Ind-Swift has got PMDA approval from Government of Japan for Pioglitazone and Risedronate Sodium to be manufactured at its facilities at Derabassi, Punjab.

Shares of Ind-Swift were at Rs 104.30, up 0.63 per cent on the NSE. It touched a high of Rs 107.50 and low of Rs 101.50 in trade so far.